Argus raises Albemarle stock price target on lithium recovery outlook

Argus has increased its price target for Albemarle Corp. to $230 from $185, while maintaining a Buy rating, based on an expected recovery in lithium pricing and earnings over the next two years. The company’s shares have outperformed the S&P 500, gaining 23% in the last three months, driven by the strong demand for lithium in EV batteries. Analyst forecasts predict earnings of $9.51 per share for fiscal 2026, with current analysis suggesting the stock is undervalued.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin